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1. IntroductIon
Anthrax is a potentially fatal disease of animals and 
human caused by a Gram positive and spore forming bacterium, 
Bacilllus anthracis. Anthrax is considered as a potential 
disease of biological warfare1. Besides, several cases of human 
and animal anthrax are reported from, any agrarian countries. 
Hence, it is imperative to develop the simple methods for 
detection of B. anthracis. 
B. anthracis harbours two mega plasmids, pXO1 (182 kb) 
and pXO2 (95 kb), which are essential for its virulence2. B. 
anthracis produces a capsule during its growth in animal or 
human host which evades the immune system3. However, in 
culture broth or in absence of pXO2 plasmid, capsule is not 
formed and a cell wall with highly patterned ultra structure 
layers is formed4. These layers that cover the entire bacterial 
cell surface are referred to as the surface layers or S-layers5,6. 
These S-layers are produced by non-covalent, entropy-driven 
self assembly of identical protein or glycoprotein subunits and 
have strong interaction with the cell wall7,8. Among the S-layer 
proteins, extractable antigen (EA1) is found abundantly on the 
surface layer of vegetative form as well as on the surface of B. 
anthracis spores9. It has also been established that EA1 is not 
the integral component of B. anthracis spores but is present as 
a contaminant during preparation of spores9. However, EA1 
is highly spore associated protein and remains bound on the 
spore surface even after rigorous washings10. Hence, it can be a 
suitable biomarker for detection of B. anthracis spores. Earlier 
studies also established the use of EA1 in the B. anthracis 
detection10-12.
Detection of B. anthracis spores is established by 
employing various methods including culturing followed by 
biochemical characterisation, immunofluorescence13, ELISA 
and other immunological systems14-17, PCR18, and surface 
plasmon resonance19. However, these methods are time 
consuming, laborious and require sophisticated laboratory 
and infrastructure. Hence, a simple, sensitive and affordable 
detection system is required for B. anthracis spores.
The recombinant proteins for use in detection and 
diagnosis are generally produced using either prokaryotic or 
eukaryotic expression systems. E. coli is the most commonly 
used host for recombinant protein production due to its fast 
growth rate and well-characterised genetics20,21. Hence, the 
objective of the present study was to produce recombinant EA1 
protein with high yield and develop an effective diagnostic test 
for detection of B. anthracis spores. The recombinant protein 
expression level in E. coli are affected by different parameters 
such as cultivation media, temperature, duration of induction, 
concentration of inducer and mode of cultivation. Hence, 
these parameters need to be optimised to enhance the yield 
of recombinant proteins. Recombinant protein production in 
E. coli has been extensively studied by batch fermentations 
using complex medium. Affinity chromatography is generally 
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employed for purification of the histidine tagged recombinant 
proteins20,22.
In this study, the rEA1 was cloned, expressed in E. coli 
and scaled up using bioreactor. The affinity purified protein 
was used to produce antibodies in rabbit and mice. An antigen 
capture ELISA was developed for detection of B. anthracis 
spores using the purified antibodies.
2. MAtErIAlS And MEthodS
2.1 bacterial Strains
Bacillus anthracis Sterne, a non-pathogenic but toxigenic 
strain and other Bacillus strains viz. B. cereus (ATCC 11778), 
B. subtilis (ATCC 6633), B. globigii (ATCC 49760), B. 
thuringiensis (MTCC 4714), B. mycoides (MTCC 645) and B. 
pumilus (MTCC 1640) were available in our laboratory. 
2.2 cloning of EA1 Gene
Genomic DNA was extracted from the overnight 
grown culture of B. anthracis Sterne in LB broth 
(Jackson et al. 1997). The primers; EA1-F (5′-
C AT G G AT C C G C A G G T A A AT C AT T C C C A G 
-3′, the BamH1 site underlined) and EA1-R (5′-
ATACTCGAGTAGATTTGGGTTATTAAGAAGG -3′, the 
XhoI site underlined) were used to amplify the eag gene 
(GenBank accession no. X99724.1). The primers were custom 
made from Eurofins, India. High fidelity DNA polymerase 
(NEB, USA) was used for PCR amplification of the target 
sequence of 2499 bp. The PCR amplification conditions were: 
initial denaturation for 2 min at 94 °C followed by 30 cycles of 
1 min at 94 °C (denaturation), 1 min at 55 °C (annealing) and 2 
min at 72 °C (extension) with a final extension of 10 min at 72 
°C. The PCR product was purified. The pET32a+ expression 
vector (Novagen, uSA) containing histidine tag was used in 
cloning. The restriction enzymes, BamH1 and Xho1 were used 
to double digest the PCR product and the vector. The digested 
products were electrophoresed (1% agarose), purified by gel 
extraction and quantified by Nanodrop Spectrophotometer 
(Corbett, Australia). For ligation, a 4:1 molar ratio of insert 
to vector was used along with T4 DNA ligase (NEB, uSA) 
at 16 °C for 12 h. The ligated plasmid was transformed into 
chemically competent E. coli DH5α and subsequently to E. 
coli BL21 (DE3), the expression host. 
2.3 Expression of rEA1 Protein
Expression of rEA1 was initially carried out at shake flask 
culture by inoculating 2% (v/v) of overnight (16 h) grown 
culture. The cultures grown in LB broth (10 ml test tube) at 37 
°C were induced with 1.0 mM IPTG at an OD600 of 0.6. After 4 
h of incubation at 180 rpm in an incubator shaker (Kuhner AG, 
Switzerland) and 37 °C, the 1 ml cultures were centrifuged at 
8000 rpm for 10 min at 4 °C. To the washed pellet, 100 µl cell 
lysis buffer was added and centrifuged at 8000 rpm for 10 min 
at 4°C. About 10 μl of supernatant sample was analysed by 
SDS-PAGE, (12% gel) in duplicate. One gel was stained with 
Coomassie brilliant blue and the other was electroblotted on to 
polyvinylidene fluoride (PVDF) membrane (Millipore, USA). 
Histidine tag at N-terminal in the rEA1 protein was confirmed 
by Western blotting with anti-His antibody (Sigma, uSA).
2.4 Effects of different Parameters on rEA1 
Protein Expression
Protein expression level depends on various factors 
including IPTG concentration, post induction time, post 
induction temperature and culture media. For optimisation of 
inducer concentration, the cells grown in LB medium were 
induced with different IPTG concentrations (0.1, 0.25, 0.5 and 
1.0 mM) for 4 h at 37 oC. Induction duration was optimised by 
inducing the cultures with 1 mM IPTG for 4 and 16 h. The post 
induction temperature of culture was optimised at 16 oC, 25 oC 
and 37 oC. After centrifugation, all the cultures were analysed 
by SDS-PAGE for protein expression. To evaluate the effect 
of culture media, five types of media viz. Luria Bertani (LB) 
Broth, Super Broth (SB), SOB, SOC and Terrific Broth were 
used for rEA1 expression. All five types of media (50 ml each) 
in duplicate containing 100 µg/ml ampicillin were inoculated 
with 1 ml of 16 h grown culture and incubated at 37 °C, 180 
rpm. When culture OD600 reached to 0.6-0.8, 1.0 mM IPTG 
was added for induction at 37 oC for 4 h. After centrifugation 
at 8000 rpm for 20 min at 4 °C, the pellets were collected and 
frozen at -20 °C. 
2.5 bioreactor Studies
The rEA1 was scaled up using 5 litre bioreactor (Bioflo 
3000: New Brunswick, uSA) under conditions described 
earlier 17, 23. The culture (5 % v/v) was inoculated in bioreactor 
vessel containing 4.5 l of TB medium with antibiotic and run 
with initial condition of temperature 37 oC, pH 7.0, agitation 
100 rpm and air 2.5 LPM. The dissolved oxygen (DO) 
concentration was kept at 20–30% of air saturation by varying 
agitation rate between 100 and 400 rpm. The cultivation pH 
was controlled between 6.8 and 7.0 using 25 % ammonia 
solution or H3PO4, whenever required. Antifoam was added to 
prevent foaming during cultivation. The cultures were grown 
till mid log phase (4 h post inoculation) and inducer (0.1 mM 
IPTG) was added for protein expression. Cells were recovered 
16 h post induction using centrifugation at 8000 rpm for 30 
min at 4 oC and stored at -20 oC. 
 
2.6 Purification of rEA1 Protein
For purification of rEA1, cell pellet was washed twice with 
distilled water and washed pellet was further dissolved (1: 10 
w/v) in cell lysis buffer. The cells were sonicated using sonicator 
(Biologics, uSA) for a total of 10 min (9 s on and 9 s off). After 
sonication, homogenate was clarified by centrifugation at 8000 
rpm for 45 min and the supernatant was collected for further 
purification. Immobilised metal affinity chromatography was 
used for purification of rEA1. After filtration through 0.45 µm 
membrane filter, the protein was purified using a 5 ml pre-
packed Ni-NTA affinity chromatography column (Qiagen, 
Germany) on AKTA Explorer chromatography system. The 
column was pre equilibrated using lysis buffer (10 CV) at a 
flow rate of 1 ml/min before sample loading. After loading 
the sample, column was washed with wash buffer containing 
50 mM imidazole and the protein was eluted in elution buffer 
containing 250 mM imidazole. All the eluted fractions were 
analysed by SDS-PAGE. Affinity chromatography purified 
protein was diafiltered in PBS containing 10% glycerol. 
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The protein concentration was assessed using BCA reagent 
(Thermo, uSA).
2.7 Analytical Methods
The culture growth was monitored by the optical density 
(OD600) measurement using spectrophotometer (Thermo, 
uSA), and wet cell weight. For wet cell weight measurement, 
10 ml of culture was centrifuged in pre-weighed 15 ml tubes 
at 8000 rpm for 20 min, and weight of pellet was taken after 
decanting the supernatant. 
SDS-PAGE was used to check expressions and purity of 
EA1 after staining with Coomassie Brilliant Blue. For Western 
blot analysis, the lysate containing EA1 as well as affinity 
chromatography purified EA1 was separated on 12 % SDS-
PAGE and transferred to PVDF membrane. The membrane was 
blocked in PBS + 5 % skimmed milk protein (SMP) at 4 °C for 
16 h. Blocked membranes were washed thrice for 5 min with 
PBS-T [PBS + 0.05 % Tween-20 (v/v)] and incubated at 37 
°C for 1 h with anti-His antibodies (1:5000 dilution in PBS+1 
% SMP). After washing, the membranes were incubated with 
rabbit anti-mouse IgG HRP conjugate (1:10000) for 1 h at 37 
°C. The membrane was developed in diaminobenzidine (DAB)/
H2O2 substrate solution for 15 min at 37 °C. 
2.8 Production and characterisation of Anti EA1 
rabbit and Mice Polyclonal Antibody (pAb)
For production of polyclonal antibodies, two male New 
Zealand white rabbits and six female BALB/c mice (8 week 
old) were used according to the Institutional Animal Ethics 
Committee (IAEC). The animals were immunised with purified 
rEA1 (200 µg/ rabbit/dose and 20-25 μg/mouse/dose) with 
Freund complete adjuvant for priming followed by two booster 
doses with incomplete adjuvant subcutaneously on days 21 and 
42. Rabbit and mice were bled before immunisation to collect 
serum. Final bleeding was carried out on day 60 and the sera 
were stored at -20 °C for further use. 
To evaluate the reactivity of rabbit and mice sera, Western 
blot analysis was carried out. Purified rEA1 was run on SDS-
PAGE and transferred on PVDF membrane and further steps 
were carried out as mentioned above with incubation in anti-
EA1 mice antiserum 1:2000 dilution and anti-EA1 rabbit 
antiserum 1:2000 dilution, respectively. The rabbit-anti-mouse 
IgG and goat- anti-rabbit IgG HRP conjugated secondary 
antibody was used for rabbit and mice sera, respectively. The 
protein bands were visualised by incubating in substrate DAB/
H2O2 for 2 min at room temperature.
To determine the antibody titre of rabbit and mice sera 
in indirect ELISA, rEA1 (200 ng/well) in coating buffer was 
added to each well of Maxisorp ELISA plates and incubated 
for 16 h at 4 °C. After washing the plates with wash buffer 
(PBS with 0.1% Tween - 20), 300 µL of blocking buffer (5% 
SMP in PBS, pH 7.2) was added to each well, and incubated 
for 1 h at 37 °C. The plates were again washed and 100 µl 
of two-fold serially diluted mice or rabbit antiserum ranging 
from 1:1000 to 1: 1024000 in 1% SMP in PBS was added to 
each well and kept for 1 h at 37 °C. The plates were washed 
again and the specifically bound antibodies were detected 
by adding 100 µl/well of HRP-conjugated anti-mice IgG 
(1:4000) or HRP- conjugate anti-rabbit IgG (1:10,000) in 
respective wells for 1 h at 37 oC. To each well, 100 µl of 
3,3’,5,5’-tetramethylbenzidine (Sigma, uSA) was added 
after three washings of plates. After 10 min incubation at 37 
°C, the reaction was stopped with 50 µl of 2.5 N H2SO4 and 
plate was read at 450 nm with ELISA plate reader (BioTek 
Instruments Inc, uSA). Serum of rabbits collected before 
immunisation was used as control. Each serum sample was 
tested in triplicate. Antibody titre was expressed as reciprocal 
of the end point dilution.
2.9 Spore Production and characterisation
For spore production, single colony of various Bacillus 
species were inoculated in BHI medium and incubated for 
16 h at 37 oC on a shaker at 170 rpm for the preparation of 
inoculum. This inoculum (10 % v/v) was used to inoculate in 
shake flask with 500 ml Difco Sporulation Medium. About 1 
ml of Ca (NO3)2 1 M, MnCl2 10 mM and FeSO4 1 mM was 
added during inoculation. The culture was incubated at 37 oC 
on an incubator shaker at 170 rpm for 72 h and analysed under 
microscope for spore formation.
To further confirm the presence of B. anthracis spores, 
10 µl of heat lysate of 107 spores/ ml of Sterne was run on 12 
% denaturing gel and transferred to PVDF membrane. After 
blocking with 5% SMP as described above, the membranes 
were incubated with anti-EA1 rabbit or mice antibodies. After 
treating with goat anti-rabbit or rabbit anti- mice IgG HRP 
conjugate for 1 h at 37 °C, the membranes were developed 
with DAB/H2O2 substrate solution for 15 min at 37 °C. 
2.10 development and Evaluation of Antigen 
capture ElISA for detection of B. anthracis 
EA1
Antigen capture ELISA was developed to detect EA1 
for B. anthracis spores. Ninety-six-well ELISA plates were 
coated with purified rabbit anti-EA1 antibodies (0.2 μg/100 
μl/ well) in coating buffer at 4 oC for overnight. Plates were 
then washed three times with PBS-T followed by incubation at 
37°C in blocking buffer for 1 h. The plates were then washed 
with PBS-T (0.1 % Tween-20 in PBS, pH 7.4) and incubated 
with different concentration of purified EA1 starting from 200 
ng to 0.39 ng / well in PBS containing 1% SMP. The plates 
were washed again after 1 h incubation at 37 °C and added 
0.2 μg/100 μl/ well anti EA1 mouse polyclonal antibody in 
1% SMP (in PBS) for 1 h at 37 oC. Rabbit anti-mouse HRP-
conjugate (1:4000) was added to the plate (100 µl/well). Plate 
was incubated at 37 oC for 1 h followed by washing with 
PBS-T. About 100 µl TMB substrate solution was then added 
per well and kept at 37 °C for 10 min. The plates were read 
at 450 nm after adding the stop solution. Each concentration 
of antigen was tested in triplicate and the mean OD for each 
sample was determined. 
The ELISA was evaluated for detection of spore of B. 
anthracis (Sterne strain). For this purpose, instead of EA1 
antigen, different numbers of spores were tested for presence 
of EA 1 on B. anthracis spores and the rEA1 antigen was 
used as a positive control. Spores were diluted in 1 % SMP in 
PBS to prepare the sample. The specificity of the ELISA was 
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evaluated with spores of other Bacillus species including B. 
cereus, B. subtilis, B. globigii, B. thuringiensis, B. mycoides 
and B. pumilus.
3. rESultS
3.1 Preparation of recombinant host and 
Expression of EA1
The DNA of B. anthracis Sterne was extracted and used 
for PCR amplification of eag gene (2499 bp). The PCR product 
was purified and cloned into pET32a+ vector using BamHI and 
XhoI restriction enzymes and transformed in E. coli DH5α. 
The cloning of PCR product into E. coli DH5α was confirmed 
by reverse restriction digestion. The plasmid from DH5α was 
purified and transformed into expression host E. coli BL21 
(DE3). The expression of rEA1 was confirmed by SDS PAGE 
(Fig. 1(a)) and Western blotting (Fig. 1(b)). 
3.2 optimisation of culture conditions for 
Expression of rEA1
Varying IPTG concentrations starting from 0.1 mM to 1.0 
mM did not show much effect on protein expression. Hence, 
0.1 mM concentration of IPTG was used in further experiments. 
Induction time of 16 h at 16 oC was found optimum for protein 
expression. Expression of protein at 16 oC was higher than at 
25 oC and 37 oC and majority of the protein was in soluble 
form. 
For optimum expression of rEA1, five different media 
were tested at shake flask culture. TB media yielded the highest 
OD of 2.36 followed by the OD values of 1.28, 2.2, 2.0 and 2.04 
in LB, SB, SOB and SOC media, respectively. TB medium 
was found better in terms of protein expression in comparison 
to other media (Fig. 2). It was also observed that induction 
at 1.0 OD600 resulted in higher level of protein expression as 
compared to induction at 0.6 OD600 in TB medium. 
The concentration of EA1 present in soluble and insoluble 
fractions in TB medium was analysed by BCA method. The 
soluble protein fraction was 70 %, whereas insoluble fraction 
was 30 % at 16 oC for 16 h induction.
3.3 Scale up Production of rEA1 using bioreactor
The rEA1 was scaled up by batch fermentation in 5 l 
bioreactor. Various parameters optimised at small scale were 
employed for this purpose. For bioreactor, cultures dissolved 
oxygen (DO) level above 20% was maintained. In batch 
fermentation, a wet cell weight of 10.5 g/l was obtained. 
3.4 Purification and characterisation of rEA1
For purification of the protein, the pellet was lysed 
and processed further for laboratory scale purification using 
immobilised metal affinity chromatography. The EA1 could 
bind onto the resin and the impurity in protein was washed 
using wash buffer. The protein was eluted with elution buffer 
containing 250 mM imidazole, pH 8.0. The protein yield of 
shake flask and batch fermentation process was 32.64 mg/l 
and 42.64 mg/l of culture, respectively. The real time profile of 
purification has been shown in Fig. 3. The SDS–PAGE analyses 
confirmed the recovery of protein by affinity purification 
(Fig. 4(a)). The purified rEA1 was reactive in Western blot 
using anti-His antibody (Fig. 4(b)). 
Figure 1. Expression profile of rEA1. (a) SDS-PAGE profile of expressed protein. Lane 1: Protein markers; lane 2: Un-induced 
culture; lane 3: induced culture containing rEA1. (b) Western blot analysis to confirm expression of rEA1. Lane 1: Protein 
markers; lane 2: Un-induced culture; lane 3: Expressed recombinant protein.
Figure 2. SDS-PAGE analysis showing effect of different media 
on expression of rEA1. Lane 1: Protein markers; 
lane 2: Un-induced culture; lane 3: LB medium; lane 
4: SB medium; lane 5: SOB medium; lane 6: SOC 
medium; lane 7: TB medium.
(b)(a)
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3.5 Determination of Anti-EA1 Rabbit and Mouse 
Polyclonal Antibody titre 
The rEA1 with Freund’s adjuvant developed higher levels 
of EA1 specific antibodies titre. The mean of the pre-immune 
sera (control sera) sample, plus three standard deviations 
(SD) was taken as the cut-off value. The antibody raised in 
rabbit and mouse exhibited a titre of 1:1024000 and 1:512000, 
respectively with rEA1 in indirect ELISA. 
3.6 Spore Production and its characterisation
In DSM medium, >95% spores were produced with 
spore count of 108 spores/ ml. Spores were characterised by 
microscopic observations. Anti-EA1 polyclonal antibodies 
were evaluated in Western blot for their potential in detection 
of spores of B. anthracis. In Western blotting, spores of B. 
anthracis Sterne were found reactive with anti-EA1 rabbit 
antibody (data not shown). Hence, EA1 can be used as a target 
for detection of B. anthracis spores. 
3.7 development and Evaluation of Antigen 
capture ElISA
We have developed antigen capture ELISA for detection 
of B. anthracis spores using polyclonal antibody of rabbit and 
mouse as capture and revealing antibody, respectively. For this 
purpose, rEA1 concentration from 200 ng to 0.39 ng/well were 
tested (Fig. 5). As low as 3.9 ng/ml of rEA could be detected 
by ELISA. For detection of B. anthracis spores, the different 
number of spores/ ml were tested for the presence of EA1. 
The ELISA could detect 103 spores/ml and so on (Fig. 6(a)). 
Further, the specificity of ELISA was confirmed using spores 
of other Bacillus species (Fig. 6(b)). No cross reactivity was 
found with spores of other Bacillus species in the developed 
ELISA. 
Figure 3. Chromatogram depicting purification of rEA1 using 
a 5-ml pre-packed Ni-NTA column on AKTA explorer 
chromatography system.
Figure 4. Characterisation of purified rEA1. (a) SDS PAGE profile. Lane 
1: Protein markers; lane 2: purified protein. (b) Western blot 
profile. Lane 1: Protein markers; lane 2: purified protein.
Figure 5. detection sensitivity of antigen capture ElISA as 
determined with varying concentration of rEA .
4. dIScuSSIon
B. anthracis has long been considered a potential biological 
warfare agent due to the formation of highly resistant spores. B. 
anthracis spores, either from soil or contaminated animal parts, 
are the infectious agent of anthrax. One of the major objectives 
of the present work was to scale up the production of rEA1 
protein of B. anthracis for development of a sensitive and 
specific immunological assay for detection of B. anthracis 
spores. Hence, in this study we have done cloning and 
expression of rEA1 of B. anthracis, its scale up, purification 
and characterisation for development of a detection assay. 
The rEA1 was expressed in E. coli. About 70 % of 
the total rEA1 was found in the soluble form. Various 
culture conditions including inducer concentration, 
duration and temperature of induction were optimised 
for enhanced expression of EA1. Varying concentration 
of IPTG did not affect protein expression at large 
extent. Induction at 16 °C for 16 h resulted in an 
increased protein expression as compared to that of 
37 °C and 25 °C. These optimised conditions resulted in 
overall higher level of protein production. 
It is well established that the culture media influence 
the recombinant protein expression levels21,22. Among the 
various growth media studied, TB medium was found to be 
better as it yielded more biomass and protein expression in 
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comparison to other growth media. Thus, TB medium was used 
for further scale up process. The higher biomass and protein 
expression in TB growth medium may be due to presence of 
glycerol as carbon source and yeast extract as nitrogen source 
along with salt components.
In this study, scale up of rEA1 was also carried out using 
bioreactor by batch cultivation. Bulk production of recombinant 
proteins having the potential of use in detection and diagnostic 
systems is desirable. Batch fermentation process has been 
successfully used for bulk production of various proteins. In 
this report, batch fermentation was done using TB growth 
medium under optimised conditions. The batch fermentation 
process resulted in 10.5 g/l of biomass which is greater than 
biomass resulted at shake flask culture using the LB (2.5 g/l) 
and TB medium (7.6 g/l). 
A single step affinity chromatography purification process 
was used for rEA1. The affinity chromatography purified 
protein was further diafiltered. The SDS-PAGE ascertained 
the molecular weight of purified EA1 as ~110 kDa (Fig. 4(a)). 
The purified protein was analysed by Western blot using anti-
histidine antibodies (Fig. 4(b)) and the results suggested that 
this protein could be used for specific detection of B. anthracis. 
The protein yield after batch fermentation process using TB 
medium was also 4-times greater (42.64 mg/l) than shake flask 
culture using LB medium (10.08 mg/l)
Previous reports have also established that anti-EA1 
antibody can be used for detection of B. anthracis spores10,11. 
Anti-EA1 monoclonal antibodies have been used even for 
detection of both, the spores as well as vegetative cells of 
B. anthracis in an earlier study 10. In this study, rabbit anti-
EA polyclonal antibodies were successfully used to detect B. 
anthracis spores (Fig. 4). The ELISA could detect 103 spores/
ml whereas spores of all the other Bacillus species including 
B. cereus, B. subtilis, B. thuringiensis, B. globigii, B. pumilus 
and B. mycoides were found negative for rEA1. Though it is 
well established that EA1 is not the component of B. anthracis 
spores, yet it is found on the surface of spores in abundance 
as contaminant during the production of spores9. EA1 is not 
released from the spore surface even after extensive washings 
during and after spore preparation10. Thus, recombinant purified 
EA1 can be used as a potential biomarker for detection of B. 
anthracis spores.
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